MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression

Triple-negative breast cancer (TNBC) has a faster rate of metastasis compared to other breast cancer subtypes, and no effective targeted therapies are currently FDA-approved. Recent data indicate that the androgen receptor (AR) promotes tumor survival and may serve as a potential therapeutic target...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Horm Cancer
Auteurs principaux: Christenson, Jessica L., Butterfield, Kiel T., Spoelstra, Nicole S., Norris, John D., Josan, Jatinder S., Pollock, Julie A., McDonnell, Donald P., Katzenellenbogen, Benita S., Katzenellenbogen, John A., Richer, Jennifer K.
Format: Artigo
Langue:Inglês
Publié: Springer US 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5407486/
https://ncbi.nlm.nih.gov/pubmed/28194662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-017-0285-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires